The Cancer Genome Atlas (TCGA) data analysis showed that LIST expression increased in a variety of tumors compared with adjacent normal tissues, especially in lung cancer, bladder urothelial carcinoma, prostate adenocarcinoma, and melanoma (Figure S3, Supporting Information). Here, CCDC152 is linked to prostate adenocarcinoma.